Ticker
YMABCompany Name
Y-MABS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Tangible Assets |
---|---|---|---|
6/30/2025 | $ 117.21M | $ 2.18M | $ 115.03M |
3/31/2025 | $ 112.61M | $ 2.21M | $ 110.4M |
12/31/2024 | $ 119.9M | $ 2.28M | $ 117.63M |
9/30/2024 | $ 120.92M | $ 2.37M | $ 118.55M |
6/30/2024 | $ 144.03M | $ 2.45M | $ 141.58M |
3/31/2024 | $ 123.31M | $ 2.54M | $ 120.77M |
12/31/2023 | $ 127.87M | $ 2.63M | $ 125.24M |
9/30/2023 | $ 128.88M | $ 2.72M | $ 126.16M |
6/30/2023 | $ 132.4M | $ 2.81M | $ 129.59M |
3/31/2023 | $ 137.44M | $ 2.9M | $ 134.55M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles
(=) Tangible Assets
Tangible Assets for Y-MABS THERAPEUTICS INC is calculated as follows: Assets [ $ 143.19M ] - Intangibles [ $ 0 ]
(=) Tangible Assets [ $ 143.19M ]
Minimum
Mar 31, 2025
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.47K |
---|---|
min | $ 0 |
max | $ 5.31B |
average | $ 996.29M |
median | $ 389.26M |
std | $ 1.28B |